Another proposed biomarker for GC patients is NF-κB, the transcription factor that interacts with multiple upstream and downstream signaling pathways, and it is thought to play an important role in the invasion, angiogenesis, and metastasis in various neoplasms, including gastric cancer [63]. Here, NFKB1 is linked to gastric cancer.